Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Ugwumba Chidozie	2. Issuer Name and Ticker or Trading Symbol BiomX Inc. [ PHGE ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner _____ Officer (give title below) __X__ Other (specify below) Exit Form 4 - former 10% owner
(Last) (First) (Middle) 609 SW 8TH STREET, SUITE 365	3. Date of Earliest Transaction (MM/DD/YYYY) 9/16/2022
(Street) BENTONVILLE, AR 72712 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	9/16/2022		S		3200	D	$0.513	3346027 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/19/2022		S		13870	D	$0.485	3332157 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/20/2022		S		10626	D	$0.451	3321531 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/21/2022		S		5574	D	$0.427	3315957 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/22/2022		S		17388	D	$0.413	3298569 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/23/2022		S		5306	D	$0.374	3293263 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/26/2022		S		17528	D	$0.355	3275735 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/27/2022		S		4866	D	$0.331	3270869 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/28/2022		S		15649	D	$0.333	3255220 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/29/2022		S		3300	D	$0.349	3251920 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	9/30/2022		S		8662	D	$0.356	3243258 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/3/2022		S		15022	D	$0.33	3228236 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/4/2022		S		19200	D	$0.344	3209036 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/5/2022		S		46785	D	$0.435	3162251 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/6/2022		S		25098	D	$0.444	3137153 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/7/2022		S		24708	D	$0.358	3112445 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/10/2022		S		10043	D	$0.326	3102402 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/11/2022		S		5988	D	$0.332	3096414 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/12/2022		S		9700	D	$0.333	3086714 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/13/2022		S		11314	D	$0.33	3075400 ⁽¹⁾	I	By SymBiosis, LLC
Common Stock	10/14/2022		S		3420	D	$0.331	3071980 ⁽¹⁾	I	By SymBiosis, LLC

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:
(1)	The shares are directly held by SymBiosis, LLC.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Ugwumba Chidozie 609 SW 8TH STREET SUITE 365 BENTONVILLE, AR 72712				Exit Form 4 - former 10% owner

Signatures
/s/ Chidozie Ugwumba		11/14/2022
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.